Veterans exposed to burn pits get new cancer screening study
NCT ID NCT07485322
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study will enroll 100 veterans aged 35 and older who were exposed to burn pits during military service. Participants will undergo a series of cancer screening tests, including a multi-cancer blood test, nasal swab, and various exams, over three years. The goal is to see if this intensive screening is feasible and satisfactory for veterans, and to explore new tools for early cancer detection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Multi-cancer blood test and nasal swab
What this could lead to
If successful, this study could show that intensive screening helps detect cancer earlier in veterans exposed to burn pits, potentially leading to better outcomes.
What could go wrong
This is a small pilot study (100 people) that is not yet recruiting. It aims to test feasibility and satisfaction, not to prove that screening saves lives. The results may not apply to all veterans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Inova Schar Cancer Institute
Fairfax, Virginia, 22031, United States
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••